Akesobio (åŗ·ę¹ēē©) IPO Trading: Action Post Near Zero Allocation
Akesobio, a China-based biotech company, raised USD 314 million at HKD 16.18 per share. The deal has attracted strong demands from both retail...
527 Views
ECM Weekly (19 Apr 2020) - Kingsoft Cloud, Akesobio, Shenzhen Hepalink, China Gas, Yageo
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We are...
454 Views
Akesobio IPO: Valuation Insights
Akeso Biopharma Inc (9926 HK) is a clinical-stage biopharmaceutical company with aims to address global unmet medical needs in oncology, immunology...
551 Views
Akesobio (åŗ·ę¹ēē©) IPO: Expect near Zero Allocation
Akesobio launched book building to raise up to USD 333 million to list in Hong Kong.Ā In our previous note, we discussed that the company features...
716 Views
ECM Weekly (12 Apr 2020) - Akesobio, Auckland Intl Airport, Oil Search, Flight Centre and More
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Our focus...
466 Views